Literature DB >> 19142019

A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Concetta G A Marfella1, Nils Henninger, Scott E LeBlanc, Namrata Krishnan, David S Garlick, Lawrence B Holzman, Anthony N Imbalzano.   

Abstract

BACKGROUND AND AIMS: Glomerular diseases are the third leading cause of kidney failure worldwide, behind only diabetes and hypertension. The molecular mechanisms underlying the cause of glomerular diseases are still largely unknown. The identification and characterization of new molecules associated with glomerular function should provide new insights into understanding the diverse group of glomerular diseases. The Chd2 protein belongs to a family of enzymes involved in ATP-dependent chromatin remodeling, suggesting that it likely functions as an epigenetic regulator of gene expression via the modification of chromatin structure.
METHODS: In this study, we present a detailed histomorphologic characterization of mice containing a mutation in the chromodomain helicase DNA-binding protein 2 (Chd2).
RESULTS: We show that Chd2-mutant mice present with glomerulopathy, proteinuria, and significantly impaired kidney function. Additionally, serum analysis revealed decreased hemoglobin and hematocrit levels in Chd2-mutant mice, suggesting that the glomerulopathy observed in these mice is associated with anemia.
CONCLUSION: Collectively, the data suggest a role for the Chd2 protein in the maintenance of kidney function. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142019      PMCID: PMC2818461          DOI: 10.1159/000190788

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  40 in total

Review 1.  Regulatory molecules in kidney development.

Authors:  C R Burrow
Journal:  Pediatr Nephrol       Date:  2000-03       Impact factor: 3.714

Review 2.  Podocyte differentiation and glomerulogenesis.

Authors:  Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

Review 3.  Biology of the human podocyte.

Authors:  Moin A Saleem
Journal:  Nephron Exp Nephrol       Date:  2003

4.  Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.

Authors:  Jay L Xue; Jennie Z Ma; Thomas A Louis; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

5.  Maintenance dialysis population dynamics: current trends and long-term implications.

Authors:  Michael J Lysaght
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

6.  Podocin localizes in the kidney to the slit diaphragm area.

Authors:  Séverine Roselli; Olivier Gribouval; Nicolas Boute; Mireille Sich; France Benessy; Tania Attié; Marie-Claire Gubler; Corinne Antignac
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 7.  Kidney development: regulatory molecules crucial to both mice and men.

Authors:  C M Bates
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

8.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Authors:  Patricia M Thompson; Takahiro Gotoh; Marleen Kok; Peter S White; Garrett M Brodeur
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

9.  Early glomerular filtration defect and severe renal disease in podocin-deficient mice.

Authors:  Séverine Roselli; Laurence Heidet; Mireille Sich; Anna Henger; Matthias Kretzler; Marie-Claire Gubler; Corinne Antignac
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Cell biology of the glomerular podocyte.

Authors:  Hermann Pavenstädt; Wilhelm Kriz; Matthias Kretzler
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

View more
  15 in total

1.  De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.

Authors:  Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig
Journal:  Am J Hum Genet       Date:  2013-10-24       Impact factor: 11.025

Review 2.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 3.  Epigenetics and hypertension.

Authors:  Richard M Millis
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 4.  Genetics and genomics of autism spectrum disorder: embracing complexity.

Authors:  Silvia De Rubeis; Joseph D Buxbaum
Journal:  Hum Mol Genet       Date:  2015-07-17       Impact factor: 6.150

5.  Epigenetics of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

Review 6.  The role of epigenetics in the pathology of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

7.  Catalog of mRNA expression patterns for DNA methylating and demethylating genes in developing mouse lower urinary tract.

Authors:  Kimberly P Keil; Helene M Altmann; Vatsal Mehta; Lisa L Abler; Erik A Elton; Chad M Vezina
Journal:  Gene Expr Patterns       Date:  2013-08-03       Impact factor: 1.224

8.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

9.  Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory.

Authors:  Young J Kim; Sattar Khoshkhoo; Jan C Frankowski; Bingyao Zhu; Saad Abbasi; Sunyoung Lee; Ye Emily Wu; Robert F Hunt
Journal:  Neuron       Date:  2018-10-18       Impact factor: 17.173

10.  New susceptibility loci associated with kidney disease in type 1 diabetes.

Authors:  Niina Sandholm; Rany M Salem; Amy Jayne McKnight; Eoin P Brennan; Carol Forsblom; Tamara Isakova; Gareth J McKay; Winfred W Williams; Denise M Sadlier; Ville-Petteri Mäkinen; Elizabeth J Swan; Cameron Palmer; Andrew P Boright; Emma Ahlqvist; Harshal A Deshmukh; Benjamin J Keller; Huateng Huang; Aila J Ahola; Emma Fagerholm; Daniel Gordin; Valma Harjutsalo; Bing He; Outi Heikkilä; Kustaa Hietala; Janne Kytö; Päivi Lahermo; Markku Lehto; Raija Lithovius; Anne-May Osterholm; Maija Parkkonen; Janne Pitkäniemi; Milla Rosengård-Bärlund; Markku Saraheimo; Cinzia Sarti; Jenny Söderlund; Aino Soro-Paavonen; Anna Syreeni; Lena M Thorn; Heikki Tikkanen; Nina Tolonen; Karl Tryggvason; Jaakko Tuomilehto; Johan Wadén; Geoffrey V Gill; Sarah Prior; Candace Guiducci; Daniel B Mirel; Andrew Taylor; S Mohsen Hosseini; Hans-Henrik Parving; Peter Rossing; Lise Tarnow; Claes Ladenvall; François Alhenc-Gelas; Pierre Lefebvre; Vincent Rigalleau; Ronan Roussel; David-Alexandre Tregouet; Anna Maestroni; Silvia Maestroni; Henrik Falhammar; Tianwei Gu; Anna Möllsten; Danut Cimponeriu; Mihai Ioana; Maria Mota; Eugen Mota; Cristian Serafinceanu; Monica Stavarachi; Robert L Hanson; Robert G Nelson; Matthias Kretzler; Helen M Colhoun; Nicolae Mircea Panduru; Harvest F Gu; Kerstin Brismar; Gianpaolo Zerbini; Samy Hadjadj; Michel Marre; Leif Groop; Maria Lajer; Shelley B Bull; Daryl Waggott; Andrew D Paterson; David A Savage; Stephen C Bain; Finian Martin; Joel N Hirschhorn; Catherine Godson; Jose C Florez; Per-Henrik Groop; Alexander P Maxwell
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.